Imprimer

Votre recherche pour: Plaques+Microarray


2 777  les résultats ont été trouvés

Affiner les résultats Trier par
SearchResultCount:"2777"

Sort Results

Vue liste Vue simple

Évaluez le résultat de cette recherche

Image non disponible-BOSSBS-6585R-CY5

Anti-DSG3 Rabbit Polyclonal Antibody (Cy5®)

Numéro de catalogue: (BOSSBS-6585R-CY5)
Fournisseur: Bioss
Description: Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-6585R-CY3

Anti-DSG3 Rabbit Polyclonal Antibody (Cy3®)

Numéro de catalogue: (BOSSBS-6585R-CY3)
Fournisseur: Bioss
Description: Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-10152R-CY7

Anti-DSG2 Rabbit Polyclonal Antibody (Cy7®)

Numéro de catalogue: (BOSSBS-10152R-CY7)
Fournisseur: Bioss
Description: Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion.
UOM: 1 * 100 µl
Image du produit-732-0380

Plate carriers for ALPS™ heat sealers

Fournisseur: THERMO MATRIX TECHNOLOGIES
Description: Thermosoudeur, accessoire, Support de plaque pour plaques PCR sans jupe, ALPS™

Environmentally Preferable

Image non disponible-CAYM38410-500

9(S)-HODE ≥98%

Fournisseur: Cayman Chemical
Description: 9(S)-HODE is produced by the lipoxygenation of linoleic acid in both plants and animals. It has been detected in atherosclerotic plaques, as an esterified component of membrane phospholipids and in oxidised LDL particles.

Image non disponible-BOSSBS-6585R-CY5.5

Anti-DSG3 Rabbit Polyclonal Antibody (Cy5.5®)

Numéro de catalogue: (BOSSBS-6585R-CY5.5)
Fournisseur: Bioss
Description: Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-10152R

Anti-DSG2 Rabbit Polyclonal Antibody

Numéro de catalogue: (BOSSBS-10152R)
Fournisseur: Bioss
Description: Component of intercellular desmosome junctions. Involved in the interaction of plaque proteins and intermediate filaments mediating cell-cell adhesion.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-2199R

Anti-APP Rabbit Polyclonal Antibody

Numéro de catalogue: (BOSSBS-2199R)
Fournisseur: Bioss
Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-0076R-CY5.5

Anti-APP Rabbit Polyclonal Antibody (Cy5.5®)

Numéro de catalogue: (BOSSBS-0076R-CY5.5)
Fournisseur: Bioss
Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-0076R-A488

Anti-APP Rabbit Polyclonal Antibody (Alexa Fluor® 488)

Numéro de catalogue: (BOSSBS-0076R-A488)
Fournisseur: Bioss
Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-0107R-A647

Anti-APP Rabbit Polyclonal Antibody (Alexa Fluor® 647)

Numéro de catalogue: (BOSSBS-0107R-A647)
Fournisseur: Bioss
Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
UOM: 1 * 100 µl
Image du produit-734-0116

Fibronectin 96-well clear flat bottom TC-treated microplates, Corning® BioCoat®

Numéro de catalogue: (734-0116)
Fournisseur: Corning
Description: Corning® BioCoat®, Plaque de culture cellulaire, Plaques à 96 puits
UOM: 1 * 5 ST

Certificats Environmentally Preferable


Image non disponible-BOSSBS-0107R-CY5

Anti-APP Rabbit Polyclonal Antibody (Cy5®)

Numéro de catalogue: (BOSSBS-0107R-CY5)
Fournisseur: Bioss
Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-0076R-A555

Anti-APP Rabbit Polyclonal Antibody (Alexa Fluor® 555)

Numéro de catalogue: (BOSSBS-0076R-A555)
Fournisseur: Bioss
Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-0076R-CY5

Anti-APP Rabbit Polyclonal Antibody (Cy5®)

Numéro de catalogue: (BOSSBS-0076R-CY5)
Fournisseur: Bioss
Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
UOM: 1 * 100 µl
Image non disponible-BOSSBS-0107R-CY3

Anti-APP Rabbit Polyclonal Antibody (Cy3®)

Numéro de catalogue: (BOSSBS-0107R-CY3)
Fournisseur: Bioss
Description: The cerebral and vascular plaques associated with Alzheimer's disease are mainly composed of Amyloid beta peptides. beta Amyloid is derived from cleavage of the Amyloid precursor protein and varies in length from 39 to 43 amino acids. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides result from cleavage of Amyloid precursor protein after residues 40, 42, and 43, respectively. The cleavage takes place by gamma-secretase during the last Amyloid precursor protein processing step. beta Amyloid [1-40], beta Amyloid [1-42], and beta Amyloid [1-43] peptides are major constituents of the plaques and tangles that occur in Alzheimer's disease. beta Amyloid and peptides have been developed as tools for elucidating the biology of Alzheimer's disease.
UOM: 1 * 100 µl
Appel de prix
Le stock de cet article est limité mais peut être disponible dans un entrepôt proche de vous. Merci de vous assurer que vous êtes connecté sur le site afin que le stock disponible soit affiché. Si l'call est toujours affiché et vous avez besoin d'aide, s'il vous plaît appelez-nous au 016 385 011
Le stock de cet article est limité mais peut être disponible dans un entrepôt proche de vous. Merci de vous assurer que vous êtes connecté sur le site afin que le stock disponible soit affiché. Si l'call est toujours affiché et vous avez besoin d'aide, s'il vous plaît appelez-nous au 016 385 011
Ces articles ne peuvent être ajoutés au Panier. Veuillez contacter votre service client ou envoyer un e-mail à vwr.be@vwr.com
Une documentation supplémentaire peut être nécessaire pour l'achat de cet article. Un représentant de VWR vous contactera si nécessaire.
Ce produit a été bloqué par votre organisation. Contacter votre service d'achat pour plus d'informations.
Le produit original n'est plus disponible. Le remplacement représenté est disponible
Les produits marqués de ce symbole ne seront bientôt plus disponibles - vente jusqu'à épuisement de stock. Des alternatives peuvent être disponibles en recherchant le code article VWR indiqué ci-dessus. Si vous avez besoin d'une assistance supplémentaire, veuillez contacter notre Service Clientèle au 016 385 011.
161 - 176 of 2 777
no targeter for Bottom